×







We sell 100% Genuine & New Books only!

Advanced Statistics in Regulatory Critical Clinical Initiatives 1st Edition 2022 Hardbound at Meripustak

Advanced Statistics in Regulatory Critical Clinical Initiatives 1st Edition 2022 Hardbound by Wei Zhang , Fangrong Yan , Feng Chen , Shein-Chung Chow , CRC Press

Books from same Author: Wei Zhang , Fangrong Yan , Feng Chen , Shein-Chung Chow

Books from same Publisher: CRC Press

Related Category: Author List / Publisher List


  • Price: ₹ 14313.00/- [ 17.00% off ]

    Seller Price: ₹ 11880.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Wei Zhang , Fangrong Yan , Feng Chen , Shein-Chung Chow
    PublisherCRC Press
    Edition1st Edition
    ISBN9780367561789
    Pages307
    BindingHardbound
    LanguageEnglish
    Publish YearApril 2022

    Description

    CRC Press Advanced Statistics in Regulatory Critical Clinical Initiatives 1st Edition 2022 Hardbound by Wei Zhang , Fangrong Yan , Feng Chen , Shein-Chung Chow

    Advanced Statistics in Regulatory Critical Clinical Initiatives is focused on the critical clinical initiatives introduced by the 21st Century Cure Act passed by the United States Congress in December 2016. The book covers everything from the outline of the initiatives to analysis on the effect on biopharmaceutical research and development. Advanced Statistics in Regulatory Critical Clinical Initiatives provides innovative ways to resolve common challenges in statistical research of rare diseases such small sample sizes and provides guidance for combined use of data. With analysis from regulatory and scientific perspectives this book is an ideal companion for researchers in biostatistics, pharmaceutical development, and policy makers in related fields.Key Features:Provides better understanding of innovative design and analysis of each critical clinical initiatives which may be used in regulatory review/approval of drug development.Makes recommendations to evaluate submissions accurately and reliably.Proposes innovative study designs and statistical methods for oncology and/or rare disease drug development.Provides insight regarding current regulatory guidance on drug development such as gene therapy and rare diseases.



    Book Successfully Added To Your Cart